1. Home
  2. RSVR vs COLL Comparison

RSVR vs COLL Comparison

Compare RSVR & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reservoir Media Inc.

RSVR

Reservoir Media Inc.

N/A

Current Price

$10.10

Market Cap

681.9M

ML Signal

N/A

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

N/A

Current Price

$24.78

Market Cap

768.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RSVR
COLL
Founded
2007
2002
Country
United States
United States
Employees
N/A
423
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
681.9M
768.2M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
RSVR
COLL
Price
$10.10
$24.78
Analyst Decision
Buy
Buy
Analyst Count
2
8
Target Price
$13.00
★ $44.00
AVG Volume (30 Days)
53.1K
★ 533.8K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 8.33
N/A
EPS
0.07
★ 0.64
Revenue
$175,664,491.00
★ $780,567,000.00
Revenue This Year
$8.25
$6.59
Revenue Next Year
$5.49
$1.89
P/E Ratio
$145.43
★ $39.44
Revenue Growth
★ 10.69
N/A
52 Week Low
$7.15
$21.43
52 Week High
$13.39
$50.79

Technical Indicators

Market Signals
Indicator
RSVR
COLL
Relative Strength Index (RSI) 54.03 53.68
Support Level $9.98 $21.67
Resistance Level $10.22 $26.39
Average True Range (ATR) 0.38 0.92
MACD -0.02 0.05
Stochastic Oscillator 33.82 44.20

Price Performance

Historical Comparison
RSVR
COLL

About RSVR Reservoir Media Inc.

Reservoir Media Inc is an independent music company. The company operates a music publishing business, a recorded music business, a management business, and a rights management entity in the Middle East. The company's segments include Music Publishing and Recorded Music. It generates the maximum of its revenue from the U.S. Music Publishing segment engaged in the acquisition of interests in music catalogs to earn royalties and signing songwriters to agreements of future delivery of songs. The Recorded Music segment involve the acquisition of sound recording catalogs and the discovery and development of recording artists and the marketing, distribution, sale and licensing of the music catalog.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: